1. Home
  2. ZUMZ vs CCCC Comparison

ZUMZ vs CCCC Comparison

Compare ZUMZ & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ZUMZ

Zumiez Inc.

HOLD

Current Price

$18.39

Market Cap

366.7M

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$3.91

Market Cap

404.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZUMZ
CCCC
Founded
1978
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
366.7M
404.7M
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
ZUMZ
CCCC
Price
$18.39
$3.91
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
$18.00
$12.20
AVG Volume (30 Days)
202.0K
2.3M
Earning Date
06-04-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
966.67
16.45
EPS
N/A
N/A
Revenue
$929,057,000.00
$35,947,000.00
Revenue This Year
$4.30
N/A
Revenue Next Year
$3.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.48
1.02
52 Week Low
$11.97
$1.36
52 Week High
$31.70
$4.60

Technical Indicators

Market Signals
Indicator
ZUMZ
CCCC
Relative Strength Index (RSI) 33.17 56.80
Support Level $15.00 $2.17
Resistance Level $22.91 $4.60
Average True Range (ATR) 1.24 0.40
MACD -0.55 -0.04
Stochastic Oscillator 32.92 42.33

Price Performance

Historical Comparison
ZUMZ
CCCC

About ZUMZ Zumiez Inc.

Zumiez Inc is a United States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art, action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

Share on Social Networks: